Ligand validation:8SY1

WZW: [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-[2-azanyl-3-[[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]imidazol-1-yl]phosphinic acid

WZW is a Ligand Of Interest in 8SY1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8SY1_WZW_C_101	54%	8%	0.119	0.883	2.29	2.37	15	18	0	0	100%	1
8SY1_WZW_B_101	52%	8%	0.13	0.887	2.04	2.6	17	14	1	0	100%	1
8SY1_WZW_D_101	48%	16%	0.088	0.927	2.14	1.58	4	3	0	0	45%	0.451
8SY1_WZW_B_102	22%	7%	0.12	0.835	2.31	2.45	5	9	0	0	45%	0.451

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.